// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

CBMT-05. ROLE OF THE let7-eEF2K AXIS IN MYC-DRIVEN MEDULLOBLASTOMA ADAPTATION TO NUTRIENT DEPRIVATION

Alberto Delaidelli - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS

Nancy Levin - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Temozolomide

ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS

Jean-Paul Bahary - Society for Neuro-Oncology (SNO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Temozolomide

- Antibodies matter: A meta-analysis of the prognostic value of human equilibrative nucleoside transporter 1 (hENT1) antibodies in pancreatobiliary cancer

D.Yusuf - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Gemcitabine

- Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival

V.Pacheco-Barcia - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Gemcitabine

SMART HUMAN NEURAL STEM CELLS TO MODIFY SCAR AND OPTIMIZE REGENERATION AFTER TRAUMATIC CERVICAL SPINAL CORD INJURY

Ahuja Christopher - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Chondroitin sulfate

KINESIN KIF2A EXPRESSION IN THE INJURED SPINAL CORD

Seira Oscar - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

METHYLPREDNISOLONE TREATMENT ENHANCES EARLY RECOVERY FOLLOWING SURGICAL DECOMPRESSION FOR DEGENERATIVE CERVICAL MYELOPATHY

Vidal Pia - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Methylprednisolone

HYPERPHOSPHORYLATED TAU AS A BIOMARKER OF TRAUMATIC AXONAL INJURY IN THE SPINAL CORD

Caprelli Mitchell - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

ASTROGLIAL CELL WOUNDING BIOMARKER ALDOLASE C IS ROBUSTLY ELEVATED IN MILD TBI PATIENTS

Van Meter Timothy - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

IMPROVING REPEATABILITY OF VERTEBRAL KINEMATICS IN A RAT DISLOCATION SPINAL CORD INJURY MODEL

Mattucci Stephen - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

DETERMINING THE RELATIVE MECHANICAL PROPERTIES OF GREY AND WHITE MATTER IN THE RAT SPINAL CORD

Sharkey Liam - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

DESIGN OF A DISLOCATION SPINAL CORD INJURY MODEL FOR EVALUATING THE EFFECT OF VELOCITY AND TIMING OF RESIDUAL COMPRESSION

Speidel Jason - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

DUAL TIME COURSE RNA-SEQ REVEALS LEVEL-SPECIFIC NEUROVASCULAR RESPONSE AFTER CERVICAL AND THORACIC SPINAL CORD INJURY

Hong James - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Reconcile

DEFINING THE BIOMECHANICAL AND BIOLOGICAL THRESHOLD OF MURINE MILD TRAUMATIC BRAIN INJURY USING CHIMERA

Bashir Asma - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

AGE HAS A GREATER INFLUENCE THAN AMYLOID BURDEN ON THE ACUTE RESPONSE TO MILD TRAUMATIC BRAIN INJURY IN MICE

Cheng Wai Hang - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

A BIOFIDELIC MOUSE MODEL OF IMPACT CONCUSSION THAT RECAPITULATES ACUTE-SUBACUTE BRAIN PATHOLOGIES ASSOCIATED WITH MILD TBI AND EAR

Wojnarowicz Mark - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

VASCULAR INTEGRITY AFTER MODERATE TRAUMATIC BRAIN INJURY IS IMPROVED WITH HUMAN UMBILICAL CORD PERIVASCULAR CELL THERAPY

Barretto Tanya - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

SHORT- AND LONG-TERM COGNITIVE DEFICITS IN PEDIATRIC MILD TRAUMATIC BRAIN INJURY

Dodd Andrew - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

ACUTE CORTISOL LEVELS MAY AID IN PREDICTING RECOVERY FOLLOWING PAEDIATRIC SPORT-RELATED CONCUSSION

Ritchie Evan - National Neurotrauma Society (NNS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Methadone hydrochloride

Copyright © 2026. QuantiNova All rights reserved